Princess Margaret Hospital, Toronto
Consolidative abdominopelvic radiotherapy treated epithelial ovarian cancer
Published in Medical Imaging Week, June 25th, 2005
In a recent study, researchers in Canada conducted a study "to assess the feasibility and morbidity of sequential cytoreductive surgery, carboplatin/paclitaxel chemotherapy, and consolidative abdominopelvic radiotherapy (APRT) in ovarian cancer. Between 1998 and 2000, 29 patients with optimally cytoreduced epithelial ovarian cancer were treated with carboplatin (135 mg/m2) and paclitaxel (area under the curve [AUC] of 6) followed by APRT in a prospective protocol."
"All patients were clinically, radiographically, and biochemically (CA-125) free of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week
Source: Medical Imaging Week (2005-06-25)
More Articles from Medical Imaging Week
- BioCurex, Inc.
Agreement signed with Goshen Cancer Center - Ehime University School of Medicine
ATP stress CE-MSCT can describe both ATP-induced ischemia and artery stenosis - Kyushu University
Angiotensin receptor blockers reverse oxidative stress in kidneys - Abant Izzet Baysal University, Bolu
Ephesos stent is a safe and effective choice - Aequitas
Findings presented for myocardial perfusion imaging - Applied Imaging Corp.
Diagnostics development deal signed with University of Vermont - More from this issue of Medical Imaging Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
